4.8 Editorial Material

Therapeutic options for the 2019 novel coronavirus (2019-nCoV)

期刊

NATURE REVIEWS DRUG DISCOVERY
卷 19, 期 3, 页码 149-150

出版社

NATURE PORTFOLIO
DOI: 10.1038/d41573-020-00016-0

关键词

-

资金

  1. National Nature Science Foundation of China [31571368, 31871324, 81730064]
  2. National Science and Technology Major Project [2018ZX10715004]
  3. Natural Science Foundation of Hunan Province [2018JJ3713]
  4. Hunan Youth Elite Project [2018RS3006]
  5. Project of Innovation-Driven Plan of Central South University [2016CX031]

向作者/读者索取更多资源

Therapeutic options in response to the 2019-nCoV outbreak are urgently needed. Here, we discuss the potential for repurposing existing antiviral agents to treat 2019-nCoV infection (now known as COVID-19), some of which are already moving into clinical trials.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据